• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未治疗的原发性甲状旁腺功能亢进的生化动力学:一项观察性研究。

BIOCHEMICAL DYNAMICS OF UNTREATED PRIMARY HYPERPARATHYROIDISM: AN OBSERVATIONAL STUDY.

出版信息

Endocr Pract. 2019 May;25(5):470-476. doi: 10.4158/EP-2018-0489. Epub 2019 Jan 18.

DOI:10.4158/EP-2018-0489
PMID:30720335
Abstract

The natural biochemical history of untreated primary hyperparathyroidism (PHPT) is poorly understood. The purpose of this study was to determine the extent of biochemical fluctuations in patients with PHPT. Retrospective cohort study from January 1, 1995, to December 31, 2014. Serum calcium and parathyroid hormone (PTH) levels in patients with classic (Ca >10.5 mg/dL, PTH >65 pg/mL) and nonclassic (Ca >10.5 mg/dL, PTH 40 to 65 pg/mL) PHPT were followed longitudinally at 1, 2, and 5 years. Biochemical profiles in follow-up were ranked in descending biochemical severity as classic PHPT, nonclassic PHPT, normal calcium with elevated PTH (Ca <10.5 mg/dL, PTH >65 pg/mL), possible PHPT (Ca >10.5 mg/dL, PTH 21 to 40 pg/mL), or absent PHPT (Ca >10.5 mg/dL, PTH <21 pg/mL or Ca <10.5 mg/dL, PTH <65 pg/mL). Of 10,598 patients, 1,570 were treated with parathyroidectomy (n = 1,433) or medications (n = 137), and 4,367 were censored due to study closure, disenrollment, or death. In the remaining 4,661 untreated patients with 5 years of follow-up, 235 (5.0%) progressed to a state of increased biochemical severity, whereas 972 (20.8%) remained the same, and 3,454 (74.1%) regressed to milder biochemical states. In 2,522 untreated patients with classic PHPT, patients most frequently transitioned to the normal calcium with elevated PTH group (n = 1,257, 49.8%). In 2,139 untreated patients with nonclassic PHPT, patients most frequently transitioned to the absent PHPT group (n = 1,354, 63.3%). PHPT is a biochemically dynamic disease with significant numbers of patients exhibiting both increases and decreases in biochemical severity. = interquartile range; = Kaiser Permanente Southern California; = primary hyperparathyroidism; = parathyroid hormone; = parathyroidectomy.

摘要

未经治疗的原发性甲状旁腺功能亢进症(PHPT)的自然生化演变过程尚不清楚。本研究旨在确定 PHPT 患者的生化波动程度。

这是一项回顾性队列研究,纳入了 1995 年 1 月 1 日至 2014 年 12 月 31 日期间的患者。对经典 PHPT(Ca>10.5mg/dL,PTH>65pg/mL)和非经典 PHPT(Ca>10.5mg/dL,PTH 40-65pg/mL)患者的血清钙和甲状旁腺激素(PTH)水平进行了 1、2 和 5 年的纵向随访。根据生化严重程度将随访中的生化谱降序排列为经典 PHPT、非经典 PHPT、血钙正常伴 PTH 升高(Ca>10.5mg/dL,PTH>65pg/mL)、可能的 PHPT(Ca>10.5mg/dL,PTH 21-40pg/mL)或无 PHPT(Ca>10.5mg/dL,PTH<21pg/mL 或 Ca<10.5mg/dL,PTH<65pg/mL)。

在 10598 例患者中,有 1570 例接受了甲状旁腺切除术(n=1433)或药物治疗(n=137),4367 例因研究结束、失访或死亡而被删失。在其余 4661 例接受 5 年随访的未经治疗的患者中,有 235 例(5.0%)进展为生化严重程度增加的状态,972 例(20.8%)保持不变,3454 例(74.1%)生化状态缓解至较轻。在 2522 例未经治疗的经典 PHPT 患者中,患者最常过渡到血钙正常伴 PTH 升高组(n=1257,49.8%)。在 2139 例未经治疗的非经典 PHPT 患者中,患者最常过渡到无 PHPT 组(n=1354,63.3%)。

PHPT 是一种生化上动态的疾病,有相当数量的患者表现出生化严重程度的增加和减少。

=四分位间距;=凯撒永久南加州;=原发性甲状旁腺功能亢进症;=甲状旁腺激素;=甲状旁腺切除术。

相似文献

1
BIOCHEMICAL DYNAMICS OF UNTREATED PRIMARY HYPERPARATHYROIDISM: AN OBSERVATIONAL STUDY.未治疗的原发性甲状旁腺功能亢进的生化动力学:一项观察性研究。
Endocr Pract. 2019 May;25(5):470-476. doi: 10.4158/EP-2018-0489. Epub 2019 Jan 18.
2
Surgical treatment of patients with mildly elevated parathormone and calcium levels.甲状旁腺激素和血钙水平轻度升高患者的手术治疗
World J Surg. 2014 Jun;38(6):1289-95. doi: 10.1007/s00268-014-2487-1.
3
Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.甲状旁腺切除术治疗血钙正常(初期)原发性甲状旁腺功能亢进症的生化和骨骼结局。
Ann Surg Oncol. 2019 Feb;26(2):539-546. doi: 10.1245/s10434-018-6998-0. Epub 2018 Nov 7.
4
Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.原发性甲状旁腺功能亢进症中的左心室肥厚。甲状旁腺切除成功后的影响。
Clin Endocrinol (Oxf). 1999 Mar;50(3):321-8. doi: 10.1046/j.1365-2265.1999.00651.x.
5
Normal PTH levels in primary hyperparathyroidism: still the same disease?原发性甲状旁腺功能亢进症中正常的甲状旁腺激素水平:仍是同一种疾病吗?
Ann Surg Oncol. 2011 Nov;18(12):3437-42. doi: 10.1245/s10434-011-1744-x. Epub 2011 May 3.
6
Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism.预防原发性和肾性甲状旁腺功能亢进患者甲状旁腺切除术后的饥饿骨综合征
Diagnostics (Basel). 2023 Jun 2;13(11):1953. doi: 10.3390/diagnostics13111953.
7
The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study.原发性甲状旁腺功能亢进症治疗与未治疗的自然史:甲状旁腺流行病学和审计研究。
QJM. 2011 Jun;104(6):513-21. doi: 10.1093/qjmed/hcq261. Epub 2011 Jan 25.
8
Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.散发性原发性甲状旁腺功能亢进症与结石病:甲状旁腺切除术前和术后的综合代谢评估
BJU Int. 2018 Feb;121(2):281-288. doi: 10.1111/bju.14072. Epub 2017 Nov 28.
9
Surgery for Primary Hyperparathyroidism with Normal Non-suppressed Parathyroid Hormone can be Both Challenging and Successful.对原发性甲状旁腺功能亢进症且甲状旁腺激素未被抑制正常的患者进行手术,既具有挑战性,也可能取得成功。
World J Surg. 2018 Feb;42(2):409-414. doi: 10.1007/s00268-017-4323-x.
10
The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels.原发性甲状旁腺功能亢进症患者术中甲状旁腺激素监测的价值及其基础甲状旁腺激素水平变化。
BJS Open. 2022 Nov 2;6(6). doi: 10.1093/bjsopen/zrac118.

引用本文的文献

1
The Eucalcemic Patient With Elevated Parathyroid Hormone Levels.甲状旁腺激素水平升高的血钙正常患者。
J Endocr Soc. 2023 Jan 26;7(4):bvad013. doi: 10.1210/jendso/bvad013. eCollection 2023 Feb 9.